Publications by authors named "Matthew A Curry"

Claim this Profile
A
A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779.
Benjamin J Dugan, Diane E Gingrich, Eugen F Mesaros, Karen L Milkiewicz, Matthew A Curry

J Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase.
Diane E Gingrich, Joseph G Lisko, Matthew A Curry, Mangeng Cheng, Matthew Quail

J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity.
Gregory R Ott, Rabindranath Tripathy, Mangeng Cheng, Robert McHugh, Andrew V Anzalone, Matthew A Curry

ACS Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis